<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang K</submitter><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>334</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12508477</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>Alpha hemolysin, a pore-forming toxin from Staphylococcus aureus, is a critical virulence factor for bacteria. Previous studies have demonstrated that the Hla mutant H35A (Hla&lt;sub>H35A&lt;/sub>) serves as a potent carrier protein for subunit vaccines, yet its immunomodulatory mechanisms remain incompletely understood. Here, we demonstrate that the Hla&lt;sub>H35A&lt;/sub> fusion enhances vaccine efficacy by targeting A Disintegrin and Metalloproteinase 10 (ADAM10) on dendritic cells (DCs), thereby activating the ADAM10-Notch signaling axis. Using the candidate antigen PA0833 from Pseudomonas aeruginosa as a model, we show that the Hla&lt;sub>H35A&lt;/sub>-PA0833 fusion protein (HPF) significantly augments antigen uptake, DC maturation, and Notch-dependent transcriptional programs, particularly in convent</pubmed_abstract><journal>Signal transduction and targeted therapy</journal><pubmed_title>Alpha hemolysin enhances the immune response by modulating dendritic cell differentiation via ADAM10-Notch signaling.</pubmed_title><pmcid>PMC12508477</pmcid><funding_grant_id>32300778</funding_grant_id><funding_grant_id>32170938</funding_grant_id><pubmed_authors>Jing H</pubmed_authors><pubmed_authors>Liao Y</pubmed_authors><pubmed_authors>Gou Q</pubmed_authors><pubmed_authors>Xia Z</pubmed_authors><pubmed_authors>Yan P</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Sun T</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Liao J</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zou Q</pubmed_authors><pubmed_authors>Liang M</pubmed_authors><pubmed_authors>Yu T</pubmed_authors><pubmed_authors>Zeng H</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alpha hemolysin enhances the immune response by modulating dendritic cell differentiation via ADAM10-Notch signaling.</name><description>Alpha hemolysin, a pore-forming toxin from Staphylococcus aureus, is a critical virulence factor for bacteria. Previous studies have demonstrated that the Hla mutant H35A (Hla&lt;sub>H35A&lt;/sub>) serves as a potent carrier protein for subunit vaccines, yet its immunomodulatory mechanisms remain incompletely understood. Here, we demonstrate that the Hla&lt;sub>H35A&lt;/sub> fusion enhances vaccine efficacy by targeting A Disintegrin and Metalloproteinase 10 (ADAM10) on dendritic cells (DCs), thereby activating the ADAM10-Notch signaling axis. Using the candidate antigen PA0833 from Pseudomonas aeruginosa as a model, we show that the Hla&lt;sub>H35A&lt;/sub>-PA0833 fusion protein (HPF) significantly augments antigen uptake, DC maturation, and Notch-dependent transcriptional programs, particularly in convent</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T09:15:51.447Z</modification><creation>2026-06-01T03:06:44.801Z</creation></dates><accession>S-EPMC12508477</accession><cross_references><pubmed>41062455</pubmed><doi>10.1038/s41392-025-02432-3</doi></cross_references></HashMap>